These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 30609166)

  • 21. Prognostic Value of High-Sensitivity Troponin-T to Identify Patients at Risk of Left Ventricular Graft Dysfunction After Heart Transplantation.
    Méndez AB; Ordonez-Llanos J; Mirabet S; Galan J; Maestre ML; Brossa V; Rivilla MT; López L; Koller T; Sionis A; Roig E
    Transplant Proc; 2016 Nov; 48(9):3021-3023. PubMed ID: 27932136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiac Power Output Index and Severe Primary Graft Dysfunction After Heart Transplantation.
    Lim HS; Ranasinghe A; Chue C; Quinn D; Mukadam M; Mascaro J
    J Cardiothorac Vasc Anesth; 2021 Feb; 35(2):398-403. PubMed ID: 32747204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased Intraoperative Fluid Administration Is Associated with Severe Primary Graft Dysfunction After Lung Transplantation.
    Geube MA; Perez-Protto SE; McGrath TL; Yang D; Sessler DI; Budev MM; Kurz A; McCurry KR; Duncan AE
    Anesth Analg; 2016 Apr; 122(4):1081-8. PubMed ID: 26991618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation of the proposed International Society for Heart and Lung Transplantation grading system for primary graft dysfunction after lung transplantation.
    Prekker ME; Nath DS; Walker AR; Johnson AC; Hertz MI; Herrington CS; Radosevich DM; Dahlberg PS
    J Heart Lung Transplant; 2006 Apr; 25(4):371-8. PubMed ID: 16563963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term effects of primary graft dysfunction after heart transplantation.
    Settepani F; Pedrazzini GL; Olivieri GM; Merlanti B; Cannata A; Lanfranconi M; Frigerio M; Russo CF
    J Card Surg; 2022 May; 37(5):1290-1298. PubMed ID: 35229361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relation of Vasoplegia in the Absence of Primary Graft Dysfunction to Mortality Following Cardiac Transplantation.
    Raza FS; Lee AY; Jamil AK; Qin H; Felius J; Rafael AE; Gonzalez-Stawinski GV; Hall SA; Joseph SM; Lima B; Bindra AS
    Am J Cardiol; 2018 Dec; 122(11):1902-1908. PubMed ID: 30442225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for primary graft failure after pediatric cardiac transplantation: importance of recipient and donor characteristics.
    Huang J; Trinkaus K; Huddleston CB; Mendeloff EN; Spray TL; Canter CE
    J Heart Lung Transplant; 2004 Jun; 23(6):716-22. PubMed ID: 15366432
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Marginal cardiac allografts do not have increased primary graft dysfunction in alternate list transplantation.
    Lima B; Rajagopal K; Petersen RP; Shah AS; Soule B; Felker GM; Rogers JG; Lodge AJ; Milano CA
    Circulation; 2006 Jul; 114(1 Suppl):I27-32. PubMed ID: 16820584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Factors Implicated in Primary Graft Dysfunction After Heart Transplantation: A Single-center Experience.
    Quintana-Quezada RA; Rajapreyar I; Postalian-Yrausquin A; Yeh YC; Choi S; Akkanti B; Sieg A; Weeks P; Patel M; Patel J; Nathan S; Kar B; Loyalka P; Gregoric I
    Transplant Proc; 2016; 48(6):2168-71. PubMed ID: 27569965
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative Evidence for Revising the Definition of Primary Graft Dysfunction after Lung Transplant.
    Cantu E; Diamond JM; Suzuki Y; Lasky J; Schaufler C; Lim B; Shah R; Porteous M; Lederer DJ; Kawut SM; Palmer SM; Snyder LD; Hartwig MG; Lama VN; Bhorade S; Bermudez C; Crespo M; McDyer J; Wille K; Orens J; Shah PD; Weinacker A; Weill D; Wilkes D; Roe D; Hage C; Ware LB; Bellamy SL; Christie JD;
    Am J Respir Crit Care Med; 2018 Jan; 197(2):235-243. PubMed ID: 28872353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence and impact of primary graft dysfunction in adult heart transplant recipients: A systematic review and meta-analysis.
    Buchan TA; Moayedi Y; Truby LK; Guyatt G; Posada JD; Ross HJ; Khush KK; Alba AC; Foroutan F
    J Heart Lung Transplant; 2021 Jul; 40(7):642-651. PubMed ID: 33947602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reoperative sternotomy is associated with primary graft dysfunction following heart transplantation.
    Still S; Shaikh AF; Qin H; Felius J; Jamil AK; Saracino G; Chamogeorgakis T; Rafael AE; MacHannaford JC; Joseph SM; Hall SA; Gonzalez-Stawinski GV; Lima B
    Interact Cardiovasc Thorac Surg; 2018 Sep; 27(3):343-349. PubMed ID: 29584854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary graft dysfunction after heart transplantation: Outcomes and resource utilization.
    Quader M; Hawkins RB; Mehaffey JH; Mazimba S; Ailawadi G; Yarboro L; Rich J; Speir A; Fonner C; Wolfe L; Kasirajan V;
    J Card Surg; 2019 Dec; 34(12):1519-1525. PubMed ID: 31609510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discontinuing amiodarone treatment prior to heart transplantation lowers incidence of severe primary graft dysfunction.
    Hoemann B; Takayama H; Jennings DL; Han J; Ando M; Restaino S; Colombo P; Farr M; Naka Y; Takeda K
    Clin Transplant; 2020 Feb; 34(2):e13779. PubMed ID: 31903624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Donor hyperoxia is a novel risk factor for severe cardiac primary graft dysfunction.
    Kransdorf EP; Rushakoff JA; Han J; Benck L; Malinoski D; Emerson D; Catarino P; Rampolla R; Kobashigawa JA; Khush KK; Patel JK
    J Heart Lung Transplant; 2023 May; 42(5):617-626. PubMed ID: 36682894
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biomarkers of cellular apoptosis and necrosis in donor myocardium are not predictive of primary graft dysfunction.
    Szarszoi O; Besik J; Smetana M; Maly J; Urban M; Maluskova J; Lodererova A; Hoskova L; Tucanova Z; Pirk J; Netuka I
    Physiol Res; 2016 Jun; 65(2):251-7. PubMed ID: 26447521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proteomic profiling identifies CLEC4C expression as a novel biomarker of primary graft dysfunction after heart transplantation.
    Truby LK; Kwee LC; Agarwal R; Grass E; DeVore AD; Patel CB; Chen D; Schroder JN; Bowles D; Milano CA; Shah SH; Holley CL
    J Heart Lung Transplant; 2021 Dec; 40(12):1589-1598. PubMed ID: 34511330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathophysiology of severe primary graft dysfunction in orthotopic heart transplantation.
    Lim HS; Ranasinghe A; Quinn D; Chue CD; Mascaro J
    Clin Transplant; 2021 Sep; 35(9):e14398. PubMed ID: 34176143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes in highly sensitized pediatric heart transplant patients using current management strategies.
    Asante-Korang A; Amankwah EK; Lopez-Cepero M; Ringewald J; Carapellucci J; Krasnopero D; Berg A; Quintessenza J; Jacobs JP
    J Heart Lung Transplant; 2015 Feb; 34(2):175-81. PubMed ID: 25447583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of the United States-derived Index for Mortality Prediction After Cardiac Transplantation (IMPACT) using international registry data.
    Kilic A; Allen JG; Weiss ES
    J Heart Lung Transplant; 2013 May; 32(5):492-8. PubMed ID: 23474362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.